Insider Trades122 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Sell | HCAT | Benjamin Albert | CEO | 34,485 | $1.69 | $166.3M | -45.32% | +135.58% | $58.3K | -2.36% | — | Stalk |
| Jun 1, 2026 | Sell | HCAT | Benjamin Albert | CEO | 336 | $1.37 | $166.3M | -45.32% | +135.58% | $460.387 | -0.02% | — | Stalk |
| Jun 1, 2026 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 8,519 | $1.37 | $166.3M | -45.32% | +135.58% | $11.7K | -2.58% | — | Stalk |
| Jun 1, 2026 | Sell | HCAT | Benjamin Landry | General Counsel | 13,779 | $1.37 | $166.3M | -45.32% | +135.58% | $18.9K | -3.64% | — | Stalk |
| Jun 1, 2026 | Sell | HCAT | Jason Alger | Chief Financial Officer | 18,804 | $1.37 | $166.3M | -45.32% | +135.58% | $25.8K | -2.54% | — | Stalk |
| May 1, 2026 | Sell | HCAT | Benjamin Albert | CEO | 310 | $1.34 | $166.3M | -45.32% | +135.58% | $416.95 | -0.02% | — | Stalk |
| Mar 10, 2026 | Sell | HCAT | Benjamin Albert | CEO | 70,455 | $1.85 | $166.3M | -45.32% | +135.58% | $130.2K | -4.61% | — | Stalk |
| Mar 2, 2026 | Sell | HCAT | Benjamin Albert | CEO | 4,966 | $1.66 | $166.3M | -45.32% | +135.58% | $8.2K | -0.32% | — | Stalk |
| Mar 2, 2026 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 13,836 | $1.66 | $166.3M | -45.32% | +135.58% | $23.0K | -4.03% | — | Stalk |
| Mar 2, 2026 | Sell | HCAT | Benjamin Landry | General Counsel | 20,838 | $1.66 | $166.3M | -45.32% | +135.58% | $34.6K | -5.22% | — | Stalk |
| Mar 2, 2026 | Sell | HCAT | Jason Alger | Chief Financial Officer | 26,970 | $1.66 | $166.3M | -45.32% | +135.58% | $44.8K | -3.51% | — | Stalk |
| Feb 26, 2026 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 4,471 | $1.75 | $166.3M | -45.32% | +135.58% | $7.8K | -1.28% | — | Stalk |
| Feb 26, 2026 | Sell | HCAT | Benjamin Landry | General Counsel | 6,317 | $1.75 | $166.3M | -45.32% | +135.58% | $11.0K | -1.56% | — | Stalk |
| Feb 26, 2026 | Sell | HCAT | Jason Alger | Chief Financial Officer | 7,522 | $1.75 | $166.3M | -45.32% | +135.58% | $13.1K | -0.97% | — | Stalk |
| Feb 26, 2026 | Sell | HCAT | Benjamin Albert | CEO | 13,304 | $1.75 | $166.3M | -45.32% | +135.58% | $23.3K | -0.86% | — | Stalk |
| Dec 5, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 27,425 | $2.64 | $166.3M | -45.32% | +135.58% | $72.3K | -21.52% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 9,762 | $2.90 | $166.3M | -45.32% | +135.58% | $28.3K | -6.38% | — | Stalk |
| Dec 1, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 14,387 | $2.90 | $166.3M | -45.32% | +135.58% | $41.7K | -10.15% | — | Stalk |
| Dec 1, 2025 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 16,401 | $2.90 | $166.3M | -45.32% | +135.58% | $47.6K | -4.37% | — | Stalk |
| Dec 1, 2025 | Sell | HCAT | Jason Alger | Chief Financial Officer | 20,619 | $2.90 | $166.3M | -45.32% | +135.58% | $59.8K | -7.72% | — | Stalk |
| Dec 1, 2025 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 55,715 | $2.90 | $166.3M | -45.32% | +135.58% | $161.6K | -3.85% | — | Stalk |
| Sep 5, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 6,175 | $3.35 | $166.3M | -45.32% | +135.58% | $20.7K | -4.17% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | HCAT | Jason Alger | Chief Financial Officer | 2,613 | $3.36 | $166.3M | -45.32% | +135.58% | $8.8K | -0.97% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 2,854 | $3.36 | $166.3M | -45.32% | +135.58% | $9.6K | -1.83% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 3,138 | $3.36 | $166.3M | -45.32% | +135.58% | $10.6K | -2.08% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | David Coy Ross | Chief Tech & Product Officer | 3,360 | $3.36 | $166.3M | -45.32% | +135.58% | $11.3K | -1.62% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 3,663 | $3.36 | $166.3M | -45.32% | +135.58% | $12.3K | -1.81% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 4,578 | $3.36 | $166.3M | -45.32% | +135.58% | $15.4K | -1.21% | — | Stalk |
| Sep 2, 2025 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 8,335 | $3.36 | $166.3M | -45.32% | +135.58% | $28.0K | -0.57% | — | Stalk |
| Jun 5, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 6,057 | $3.94 | $166.3M | -45.32% | +135.58% | $23.9K | -3.85% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | HCAT | Jason Alger | Chief Financial Officer | 2,712 | $3.63 | $166.3M | -45.32% | +135.58% | $9.9K | -1.00% | — | Stalk |
| Jun 2, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 2,965 | $3.63 | $166.3M | -45.32% | +135.58% | $10.8K | -1.87% | — | Stalk |
| Jun 2, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 3,255 | $3.63 | $166.3M | -45.32% | +135.58% | $11.8K | -2.03% | — | Stalk |
| Jun 2, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 3,802 | $3.63 | $166.3M | -45.32% | +135.58% | $13.8K | -1.85% | — | Stalk |
| Jun 2, 2025 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 4,747 | $3.63 | $166.3M | -45.32% | +135.58% | $17.3K | -1.23% | — | Stalk |
| Jun 2, 2025 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 8,658 | $3.63 | $166.3M | -45.32% | +135.58% | $31.5K | -0.59% | — | Stalk |
| May 5, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $4.10 | $166.3M | -45.32% | +135.58% | $21.3K | -2.47% | 10b5-1 | Stalk |
| Apr 3, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $4.15 | $166.3M | -45.32% | +135.58% | $21.6K | -2.41% | 10b5-1 | Stalk |
| Mar 6, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 13,827 | $4.55 | $166.3M | -45.32% | +135.58% | $62.9K | -7.93% | 10b5-1 | Stalk |
| Mar 5, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 16,902 | $4.52 | $166.3M | -45.32% | +135.58% | $76.3K | -7.25% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | HCAT | Jason Alger | Chief Financial Officer | 7,304 | $4.58 | $166.3M | -45.32% | +135.58% | $33.4K | -2.61% | — | Stalk |
| Mar 3, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 7,525 | $4.58 | $166.3M | -45.32% | +135.58% | $34.4K | -4.52% | — | Stalk |
| Mar 3, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 9,024 | $4.58 | $166.3M | -45.32% | +135.58% | $41.3K | -4.92% | — | Stalk |
| Mar 3, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 9,232 | $4.58 | $166.3M | -45.32% | +135.58% | $42.3K | -3.81% | — | Stalk |
| Mar 3, 2025 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 10,800 | $4.58 | $166.3M | -45.32% | +135.58% | $49.4K | -2.73% | — | Stalk |
| Mar 3, 2025 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 33,677 | $4.58 | $166.3M | -45.32% | +135.58% | $154.1K | -2.25% | — | Stalk |
| Feb 18, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 6,441 | $5.43 | $166.3M | -45.32% | +135.58% | $35.0K | -6.98% | 10b5-1 | Stalk |
| Feb 5, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $5.76 | $166.3M | -45.32% | +135.58% | $30.0K | -5.71% | 10b5-1 | Stalk |
| Jan 15, 2025 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 6,442 | $5.80 | $166.3M | -45.32% | +135.58% | $37.3K | -6.53% | 10b5-1 | Stalk |
| Jan 6, 2025 | Sell | HCAT | Benjamin Landry | General Counsel | 2,500 | $7.52 | $166.3M | -45.32% | +135.58% | $18.8K | -3.34% | 10b5-1 | Stalk |
| Jan 6, 2025 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $7.51 | $166.3M | -45.32% | +135.58% | $39.1K | -5.40% | 10b5-1 | Stalk |
| Dec 16, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 6,442 | $7.88 | $166.3M | -45.32% | +135.58% | $50.8K | -6.13% | 10b5-1 | Stalk |
| Dec 6, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 19,268 | $8.32 | $166.3M | -45.32% | +135.58% | $160.3K | -21.05% | 10b5-1 | Stalk |
| Dec 6, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 19,599 | $8.32 | $166.3M | -45.32% | +135.58% | $163.0K | -18.44% | 10b5-1 | Stalk |
| Dec 4, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 22,773 | $7.70 | $166.3M | -45.32% | +135.58% | $175.2K | -19.10% | 10b5-1 | Stalk |
| Dec 1, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 7,766 | $8.97 | $166.3M | -45.32% | +135.58% | $69.7K | -6.88% | — | Stalk |
| Dec 1, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 7,795 | $8.97 | $166.3M | -45.32% | +135.58% | $69.9K | -6.83% | — | Stalk |
| Dec 1, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 9,419 | $8.97 | $166.3M | -45.32% | +135.58% | $84.5K | -9.33% | — | Stalk |
| Dec 1, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 10,455 | $8.97 | $166.3M | -45.32% | +135.58% | $93.8K | -8.06% | — | Stalk |
| Dec 1, 2024 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 18,931 | $8.96 | $166.3M | -45.32% | +135.58% | $169.6K | -3.78% | 10b5-1 | Stalk |
| Dec 1, 2024 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 30,897 | $8.97 | $166.3M | -45.32% | +135.58% | $277.2K | -2.67% | — | Stalk |
| Nov 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,365 | $8.50 | $166.3M | -45.32% | +135.58% | $11.6K | -1.19% | 10b5-1 | Stalk |
| Nov 5, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $7.70 | $166.3M | -45.32% | +135.58% | $40.1K | -3.86% | 10b5-1 | Stalk |
| Oct 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,324 | $8.16 | $166.3M | -45.32% | +135.58% | $10.8K | -1.15% | 10b5-1 | Stalk |
| Oct 3, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $7.68 | $166.3M | -45.32% | +135.58% | $40.0K | -3.72% | 10b5-1 | Stalk |
| Sep 16, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,324 | $8.43 | $166.3M | -45.32% | +135.58% | $11.2K | -1.13% | 10b5-1 | Stalk |
| Sep 6, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 2,466 | $7.39 | $166.3M | -45.32% | +135.58% | $18.2K | -2.38% | 10b5-1 | Stalk |
| Sep 6, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 2,899 | $7.39 | $166.3M | -45.32% | +135.58% | $21.4K | -2.48% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 1,165 | $7.27 | $166.3M | -45.32% | +135.58% | $8.5K | -0.99% | — | Stalk |
| Sep 3, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 1,222 | $7.27 | $166.3M | -45.32% | +135.58% | $8.9K | -1.17% | — | Stalk |
| Sep 3, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,613 | $7.27 | $166.3M | -45.32% | +135.58% | $11.7K | -1.36% | — | Stalk |
| Sep 3, 2024 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 4,174 | $7.27 | $166.3M | -45.32% | +135.58% | $30.3K | -0.36% | — | Stalk |
| Sep 3, 2024 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 10,272 | $7.24 | $166.3M | -45.32% | +135.58% | $74.3K | -1.94% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 9,898 | $7.53 | $166.3M | -45.32% | +135.58% | $74.5K | -3.32% | 10b5-1 | Stalk |
| Aug 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,328 | $6.57 | $166.3M | -45.32% | +135.58% | $8.7K | -1.11% | 10b5-1 | Stalk |
| Aug 5, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,209 | $6.19 | $166.3M | -45.32% | +135.58% | $32.2K | -3.36% | 10b5-1 | Stalk |
| Jul 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,290 | $6.51 | $166.3M | -45.32% | +135.58% | $8.4K | -1.06% | 10b5-1 | Stalk |
| Jul 3, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 5,208 | $6.15 | $166.3M | -45.32% | +135.58% | $32.0K | -3.25% | 10b5-1 | Stalk |
| Jun 17, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,290 | $6.37 | $166.3M | -45.32% | +135.58% | $8.2K | -1.05% | 10b5-1 | Stalk |
| Jun 12, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 2,823 | $6.83 | $166.3M | -45.32% | +135.58% | $19.3K | -2.33% | 10b5-1 | Stalk |
| Jun 11, 2024 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 7,500 | $6.53 | $166.3M | -45.32% | +135.58% | $49.0K | -2.74% | 10b5-1 | Stalk |
| Jun 6, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 2,387 | $6.71 | $166.3M | -45.32% | +135.58% | $16.0K | -2.23% | 10b5-1 | Stalk |
| Jun 6, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 11,923 | $6.72 | $166.3M | -45.32% | +135.58% | $80.1K | -6.92% | 10b5-1 | Stalk |
| Jun 3, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 1,238 | $6.53 | $166.3M | -45.32% | +135.58% | $8.1K | -1.01% | — | Stalk |
| Jun 3, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,716 | $6.53 | $166.3M | -45.32% | +135.58% | $11.2K | -1.38% | — | Stalk |
| Jun 3, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 1,873 | $6.53 | $166.3M | -45.32% | +135.58% | $12.2K | -1.08% | — | Stalk |
| Jun 3, 2024 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 2,951 | $6.53 | $166.3M | -45.32% | +135.58% | $19.3K | -1.07% | — | Stalk |
| Jun 3, 2024 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 4,442 | $6.53 | $166.3M | -45.32% | +135.58% | $29.0K | -0.38% | — | Stalk |
| May 31, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 13,877 | $6.60 | $166.3M | -45.32% | +135.58% | $91.6K | -6.05% | 10b5-1 | Stalk |
| May 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 2,066 | $7.00 | $166.3M | -45.32% | +135.58% | $14.5K | -1.64% | 10b5-1 | Stalk |
| Apr 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 2,005 | $6.11 | $166.3M | -45.32% | +135.58% | $12.3K | -1.56% | 10b5-1 | Stalk |
| Mar 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 2,005 | $7.80 | $166.3M | -45.32% | +135.58% | $15.6K | -1.54% | 10b5-1 | Stalk |
| Mar 1, 2024 | Sell | HCAT | Jason Alger | Chief Financial Officer | 2,474 | $8.05 | $166.3M | -45.32% | +135.58% | $19.9K | -4.52% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Daniel Lesueur | Chief Operating Officer | 3,279 | $8.05 | $166.3M | -45.32% | +135.58% | $26.4K | -3.05% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Benjamin Landry | General Counsel | 3,315 | $8.05 | $166.3M | -45.32% | +135.58% | $26.7K | -2.67% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 3,439 | $8.05 | $166.3M | -45.32% | +135.58% | $27.7K | -2.57% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 4,540 | $8.05 | $166.3M | -45.32% | +135.58% | $36.6K | -1.61% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 4,973 | $8.05 | $166.3M | -45.32% | +135.58% | $40.0K | -0.42% | — | Stalk |
| Mar 1, 2024 | Sell | HCAT | Bryan Truman Hunt | Chief Financial Officer | 11,684 | $8.05 | $166.3M | -45.32% | +135.58% | $94.1K | -5.05% | — | Stalk |
| Feb 27, 2024 | Buy | HCAT | Daniel D. Burton | Chief Executive Officer | 26,200 | $7.81 | $166.3M | -45.32% | +135.58% | $204.5K | +2.29% | — | Stalk |
| Feb 15, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 3,262 | $9.77 | $166.3M | -45.32% | +135.58% | $31.9K | -4.79% | 10b5-1 | Stalk |
| Jan 16, 2024 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 3,163 | $10.83 | $166.3M | -45.32% | +135.58% | $34.2K | -4.44% | 10b5-1 | Stalk |
| Dec 15, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 3,163 | $8.83 | $166.3M | -45.32% | +135.58% | $27.9K | -4.25% | 10b5-1 | Stalk |
| Dec 6, 2023 | Sell | HCAT | Jason Alger | Chief Accounting Officer | 2,177 | $7.55 | $166.3M | -45.32% | +135.58% | $16.4K | -4.02% | 10b5-1 | Stalk |
| Dec 1, 2023 | Sell | HCAT | Jason Alger | Chief Accounting Officer | 2,838 | $7.45 | $166.3M | -45.32% | +135.58% | $21.1K | -4.98% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 2,921 | $7.45 | $166.3M | -45.32% | +135.58% | $21.8K | -1.71% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Benjamin Landry | General Counsel | 3,427 | $7.45 | $166.3M | -45.32% | +135.58% | $25.5K | -7.11% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Anne Marie Bickmore | COO and Chief Product Officer | 4,114 | $7.45 | $166.3M | -45.32% | +135.58% | $30.7K | -6.06% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 4,161 | $7.45 | $166.3M | -45.32% | +135.58% | $31.0K | -5.30% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 8,478 | $7.45 | $166.3M | -45.32% | +135.58% | $63.2K | -0.94% | — | Stalk |
| Dec 1, 2023 | Sell | HCAT | Bryan Truman Hunt | Chief Financial Officer | 14,118 | $7.45 | $166.3M | -45.32% | +135.58% | $105.2K | -6.02% | — | Stalk |
| Nov 15, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,196 | $8.25 | $166.3M | -45.32% | +135.58% | $9.9K | -1.50% | 10b5-1 | Stalk |
| Oct 16, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,161 | $8.33 | $166.3M | -45.32% | +135.58% | $9.7K | -1.44% | 10b5-1 | Stalk |
| Sep 15, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,160 | $11.01 | $166.3M | -45.32% | +135.58% | $12.8K | -1.41% | 10b5-1 | Stalk |
| Sep 1, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 1,484 | $11.78 | $166.3M | -45.32% | +135.58% | $17.5K | -1.78% | — | Stalk |
| Sep 1, 2023 | Sell | HCAT | Benjamin Landry | General Counsel | 1,657 | $11.60 | $166.3M | -45.32% | +135.58% | $19.2K | -2.80% | 10b5-1 | Stalk |
| Sep 1, 2023 | Sell | HCAT | Anne Marie Bickmore | COO and Chief Product Officer | 1,682 | $11.78 | $166.3M | -45.32% | +135.58% | $19.8K | -2.42% | — | Stalk |
| Sep 1, 2023 | Sell | HCAT | Jason Alger | Chief Accounting Officer | 3,126 | $11.69 | $166.3M | -45.32% | +135.58% | $36.5K | -2.62% | 10b5-1 | Stalk |
| Sep 1, 2023 | Sell | HCAT | Bryan Truman Hunt | Chief Financial Officer | 4,128 | $11.78 | $166.3M | -45.32% | +135.58% | $48.6K | -1.73% | — | Stalk |
| Sep 1, 2023 | Sell | HCAT | Daniel D. Burton | Chief Executive Officer | 7,103 | $11.78 | $166.3M | -45.32% | +135.58% | $83.6K | -0.78% | — | Stalk |
| Sep 1, 2023 | Sell | HCAT | Kevin Lee Freeman | Chief Commercial Officer | 8,460 | $11.78 | $166.3M | -45.32% | +135.58% | $99.6K | -4.72% | — | Stalk |
| Aug 22, 2023 | Sell | HCAT | Linda Llewelyn | Chief People Officer | 737 | $11.90 | $166.3M | -45.32% | +135.58% | $8.8K | -0.87% | 10b5-1 | Stalk |